Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Cytomegalovirus, aging, and HIV: a perfect storm.

Barrett L, Fowke KR, Grant MD.

AIDS Rev. 2012 Jul-Sep;14(3):159-67. Review.

PMID:
22833059
2.

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.

Appay V, Fastenackels S, Katlama C, Ait-Mohand H, Schneider L, Guihot A, Keller M, Grubeck-Loebenstein B, Simon A, Lambotte O, Hunt PW, Deeks SG, Costagliola D, Autran B, Sauce D.

AIDS. 2011 Sep 24;25(15):1813-22. doi: 10.1097/QAD.0b013e32834640e6.

PMID:
21412126
3.
4.

Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.

Gerna G, Piccinini G, Genini E, Percivalle E, Zavattoni M, Lilleri D, Testa L, Comolli G, Maserati R, Baldanti F, Maccario R, Monforte AD, Revello MG.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):320-31.

PMID:
11707667
5.

Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.

Tamarit A, Alberola J, Mir A, Benet I, Mira JV, Muñoz C, Galindo MJ, Navarro D.

J Clin Virol. 2004 Apr;29(4):308-14.

PMID:
15018860
6.

Immune resilience in HIV-infected individuals seronegative for cytomegalovirus.

Barrett L, Stapleton SN, Fudge NJ, Grant MD.

AIDS. 2014 Sep 10;28(14):2045-9. doi: 10.1097/QAD.0000000000000405.

PMID:
25265072
7.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

PMID:
11443550
8.

Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.

Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.

J Infect Dis. 2005 Mar 15;191(6):873-80. Epub 2005 Jan 31.

PMID:
15717261
9.

Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.

Geertsma MF, van Wengen-Stevenhagen A, van Dam EM, Risberg K, Kroon FP, Groeneveld PH, Nibbering PH.

J Infect Dis. 1999 Sep;180(3):649-58.

PMID:
10438351
10.

Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.

Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.

J Infect Dis. 2001 Apr 15;183(8):1285-9. Epub 2001 Mar 12.

PMID:
11262214
11.

Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

Harari A, Rizzardi GP, Ellefsen K, Ciuffreda D, Champagne P, Bart PA, Kaufmann D, Telenti A, Sahli R, Tambussi G, Kaiser L, Lazzarin A, Perrin L, Pantaleo G.

Blood. 2002 Aug 15;100(4):1381-7.

12.

Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy.

Deayton JR, Sabin CA, Britt WB, Jones IM, Wilson P, Johnson MA, Griffiths PD, Emery VC.

AIDS. 2002 Nov 8;16(16):2129-35.

PMID:
12409733
13.

Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Freeman ML, Lederman MM, Gianella S.

Curr HIV/AIDS Rep. 2016 Feb;13(1):10-9. doi: 10.1007/s11904-016-0297-9. Review.

14.

Acute cytomegalovirus infection in AIDS patients with CD4 counts above 100 x 10(6) cells/l following combination antiretroviral therapy including protease inhibitors.

Gilquin J, Piketty C, Thomas V, Gonzales-Canali G, Belec L, Kazatchkine MD.

AIDS. 1997 Nov;11(13):1659-60. No abstract available.

PMID:
9365778
15.
16.

Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.

Mihăilescu R, Arama V, Paraschiv S, Streinu-Cercel A, Oţelea D, Munteanu D, Iosipenco M, Chiotan C, Benea OE, Mărdărescu M, Rădulescu M, Hristea A, Ungurianu R, Aramă SS, Cercel AS, Călin R, Băicuş C.

Rom J Intern Med. 2008;46(4):305-11.

PMID:
19480296
17.

Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.

Weinberg A, Tierney C, Kendall MA, Bosch RJ, Patterson-Bartlett J, Erice A, Hirsch MS, Polsky B; AIDS Clinical Trials Group 360 Team.

J Infect Dis. 2006 Feb 15;193(4):488-93. Epub 2006 Jan 3.

PMID:
16425127
18.

Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1.

Doyle M, Atkins JT, Rivera-Matos IR.

Pediatr Infect Dis J. 1996 Dec;15(12):1102-6.

PMID:
8970220
19.

Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.

Behrens GM, Meyer D, Stoll M, Schmidt RE.

Immunobiology. 2000 Aug;202(2):186-93.

PMID:
10993293
20.

Cytomegalovirus as a co-factor of disease progression in human immunodeficiency virus type 1 infection.

Nardiello S, Digilio L, Pizzella T, Galanti B.

Int J Clin Lab Res. 1994;24(2):86-9. Review.

PMID:
7919433

Supplemental Content

Support Center